• LAST PRICE
    7.6900
  • TODAY'S CHANGE (%)
    Trending Up0.1900 (2.5333%)
  • Bid / Lots
    7.4400/ 6
  • Ask / Lots
    7.8000/ 2
  • Open / Previous Close
    7.5200 / 7.5000
  • Day Range
    Low 7.4050
    High 7.7700
  • 52 Week Range
    Low 6.7950
    High 30.8700
  • Volume
    274,323
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Tuesday's close: 7.5
TimeVolumePASG
09:32 ET14497.57
09:33 ET12007.405
09:35 ET2307.405
09:42 ET15657.42
09:44 ET1007.46
09:46 ET1007.45
09:50 ET8157.54
09:53 ET3007.54
09:57 ET4007.49
10:02 ET4007.53
10:04 ET1007.505
10:06 ET5007.51
10:09 ET1007.51
10:11 ET3007.54
10:15 ET2757.5688
10:22 ET1507.5658
10:24 ET2117.58
10:26 ET2007.63
10:29 ET44917.615
10:31 ET1007.62
10:33 ET169297.73
10:36 ET1007.73
10:38 ET12007.7
10:40 ET6007.74
10:42 ET103007.69
10:44 ET3007.66
10:47 ET1007.61
10:49 ET15017.61
10:51 ET22007.63
10:54 ET4007.64
10:56 ET3557.7
10:58 ET3007.7
11:00 ET2007.68
11:02 ET2207.7
11:03 ET3007.7
11:05 ET1007.68
11:07 ET1007.705
11:09 ET8007.63
11:12 ET4007.645
11:14 ET1007.665
11:16 ET4007.65
11:18 ET2007.67
11:20 ET1007.685
11:23 ET1007.68
11:25 ET5007.67
11:27 ET6007.645
11:30 ET1007.62
11:32 ET2007.62
11:34 ET2457.62
11:36 ET4007.615
11:38 ET3007.68
11:39 ET2007.68
11:41 ET3007.69
11:43 ET7007.69
11:45 ET3007.675
11:48 ET1007.69
11:50 ET2007.68
11:52 ET10007.69
11:54 ET3067.67
11:56 ET2007.66
11:57 ET2007.69
11:59 ET3007.66
12:01 ET4007.6345
12:03 ET34207.63
12:08 ET2007.64
12:12 ET1007.65
12:14 ET6007.63
12:15 ET1007.63
12:17 ET1107.625
12:21 ET1007.62
12:24 ET1007.58
12:26 ET3277.62
12:28 ET1007.63
12:33 ET1007.6
12:35 ET4297.6
12:46 ET3007.595
12:51 ET1007.59
12:55 ET3007.6
01:00 ET1007.615
01:02 ET6037.63
01:04 ET1007.65
01:06 ET9317.62
01:09 ET4027.585
01:11 ET1007.59
01:15 ET15757.615
01:18 ET1007.605
01:22 ET3007.615
01:24 ET2007.62
01:26 ET1007.62
01:27 ET3007.635
01:33 ET1007.625
01:36 ET1007.63
01:38 ET4817.62
01:40 ET1007.615
01:42 ET1907.63
01:44 ET7007.63
01:45 ET1007.63
01:47 ET3007.62
01:49 ET4007.63
01:51 ET3007.62
01:56 ET6007.6
01:58 ET8007.6
02:00 ET2007.59
02:02 ET15587.59
02:03 ET2007.575
02:05 ET4007.59
02:07 ET1007.59
02:09 ET1007.59
02:12 ET1207.59
02:14 ET13247.6
02:20 ET1007.59
02:21 ET1007.6
02:27 ET1007.6
02:30 ET4007.57
02:32 ET1007.59
02:34 ET1007.6
02:36 ET3007.615
02:38 ET9007.63
02:39 ET2007.635
02:41 ET3007.62
02:43 ET2007.62
02:45 ET2007.62
02:50 ET1007.61
02:52 ET2267.61
02:54 ET28847.6
02:56 ET1007.61
03:01 ET7007.62
03:06 ET6007.59
03:08 ET1007.585
03:10 ET1007.58
03:12 ET1007.57
03:17 ET8207.565
03:21 ET1007.57
03:24 ET4327.55
03:26 ET1507.55
03:28 ET12907.57
03:30 ET1007.57
03:32 ET3007.58
03:33 ET6007.57
03:35 ET35087.575
03:37 ET29727.6
03:39 ET11677.62
03:42 ET25907.61
03:44 ET24007.61
03:46 ET986197.6
03:48 ET11607.63
03:50 ET23507.665
03:51 ET22007.67
03:53 ET57017.7
03:55 ET21267.69
03:57 ET23397.69
04:00 ET185227.69
Data delayed at least 15 minutes.

Today

Nov 30, 2021

Nov 19, 2021

1 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesPASG
Passage Bio Inc
405.8M
-2.3x
---
United StatesVKTX
Viking Therapeutics Inc
408.4M
-7.4x
---
United StatesPRVB
Provention Bio Inc
408.8M
-3.4x
---
United StatesFHTX
Foghorn Therapeutics Inc.
402.4M
-5.4x
---
United StatesRLYB
Rallybio Corp
397.4M
0.0x
---
United StatesCRTX
Cortexyme Inc
391.4M
-4.8x
---
As of 2021-12-08

Company Information

Passage Bio, Inc. is a clinical-stage genetic medicines company. It is focused on developing transformative therapies for central nervous system (CNS) disorders. Its first product candidate, PBGM01, utilizes AAVhu68 capsid to deliver to the brain and peripheral tissues a functional GLB1 gene encoding lysosomal beta-galactosidase (β-gal) for gangliosidosis (GM1). Its second product candidate, PBFT02, utilizes AAV1 capsid to deliver to the brain a functional GRN gene encoding progranulin (PGRN) for frontotemporal dementia (FTD) caused by progranulin deficiency (FTD-GRN). Its third product candidate, PBKR03, utilizes AAVhu68 capsid to deliver to the brain and peripheral tissues a functional gene encoding the hydrolytic enzyme galactosylceramidase (GALC) for Krabbe disease. It also has four programs in the research stage: PBML04 for metachromatic leukodystrophy (MLD); PBAL05 for amyotrophic lateral sclerosis (ALS); PBCM06 for Charcot-Marie-Tooth Type 2A (CMT2A), and other.

Contact Information

Headquarters
One Commerce Square 2005 Market Street, 39Th FloorPHILADELPHIA, PA, United States 19103
Phone
267-866-0312
Fax
302-655-5049

Executives

Chairwoman of the Board
Maxine Gowen
President, Chief Executive Officer, Director
Bruce Goldsmith
Chief Financial Officer
Simona King
Chief Operating Officer
Jill Quigley
Chief Technical Officer
Alexandros Fotopoulos

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$405.8M
Revenue (TTM)
$0.00
Shares Outstanding
54.1M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
---
EPS
$-3.38
Book Value
$6.68
P/E Ratio
-2.3x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.